{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:04:16Z","timestamp":1783958656739,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ccell.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:05:36Z","timestamp":1783955136000},"page":"1330-1332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Starved of oxygen and fueled by macrophages: Path to progression in RCC"],"prefix":"10.1016","volume":"44","author":[{"given":"Luigi","family":"Perelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannicola","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar M.","family":"Tannir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2026.06.005_bib1","doi-asserted-by":"crossref","first-page":"e251201","DOI":"10.1001\/jamanetworkopen.2025.1201","article-title":"Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US","volume":"8","author":"Ozay","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ccell.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1200\/JCO.22.00868","article-title":"Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline","volume":"40","author":"Rathmell","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1200\/JCO.23.01569","article-title":"Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study","volume":"42","author":"Motzer","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.06.005_bib4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ccell.2026.05.007","article-title":"Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma","volume":"44","author":"Vuong","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.36401\/JIPO-20-32","article-title":"Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors","volume":"4","author":"Lin","year":"2021","journal-title":"J. Immunother. Precis. Oncol."},{"key":"10.1016\/j.ccell.2026.06.005_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1200\/JCO.2005.01.186","article-title":"Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma","volume":"23","author":"Rini","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.06.005_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41586-024-07812-3","article-title":"Mitochondrial complex I promotes kidney cancer metastasis","volume":"633","author":"Bezwada","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.06.005_bib8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s43018-023-00584-1","article-title":"Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer","volume":"4","author":"Perelli","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2026.06.005_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41559-021-01586-x","article-title":"Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study","volume":"6","author":"Fu","year":"2021","journal-title":"Nat. Ecol. Evol."},{"key":"10.1016\/j.ccell.2026.06.005_bib10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.annonc.2024.07.727","article-title":"Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial","volume":"35","author":"Tannir","year":"2024","journal-title":"Ann. Oncol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610826002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610826002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:07:09Z","timestamp":1783955229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610826002928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1535610826002928"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2026.06.005","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Starved of oxygen and fueled by macrophages: Path to progression in RCC","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2026.05.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}